GlassScriptPhysician profile
Emmanuel Ekanem
NPI 1407274327
$132,076.98
in general payments reported to CMS, 2019-2025
19 companies · $67K in 2025
The $67K reported for 2025 was more than what 99% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,111 · 2020: $1,484 · 2021: $700 · 2022: $15K · 2023: $9,026 · 2024: $37K · 2025: $67K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $49K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $36K · Travel and Lodging: $15K · Food and Beverage: $13K · Education: $576.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $48,550.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $35,625.00 |
| Travel and Lodging | $14,700.47 |
| Food and Beverage | $13,090.27 |
| Education | $575.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $53,378.80 | 2021-2025 | Farapulse, General - Therapies, General - Ep |
| Biosense Webster, INC. | $35,336.12 | 2024-2025 | Carto 3, Nuvision Ice Catheter, Qdot Micro Catheter |
| Medical Device Business Services, INC. | $18,434.35 | 2024-2025 | Carto 3 |
| Abbott Laboratories | $11,459.24 | 2019-2025 | Aveir, Ensite, Gallant |
| Biotronik INC. | $4,854.91 | 2022-2023 | Acticor 7 Vr-T Dx, Rivacor 7 Dr-T, Sentus |
| Medtronic, INC. | $4,455.59 | 2021-2025 | Cobalt Dr Mri Surescan, Micra, Pulseselect |
| Medtronic Vascular, INC. | $3,336.52 | 2019-2020 | |
| Cardiva Medical, INC. | $189.29 | 2021-2023 | Cardiva Vascade 5f Vcs |
| Pfizer INC. | $169.79 | 2019-2025 | |
| Cardiovascular Systems INC. | $111.59 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $95.63 | 2023-2025 | Jardiance |
| Novo Nordisk INC | $51.33 | 2024-2025 | Wegovy, Ozempic |
| E.R. Squibb & Sons, L.L.C. | $49.19 | 2019-2023 | Eliquis |
| Astrazeneca Pharmaceuticals LP | $39.05 | 2022-2023 | Andexxa |
| Kestra Medical Technology Services, INC. | $31.29 | 2025 | Assure Wcd |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $31.05 | 2023 | Alphavac |
| Terumo Medical Corporation | $20.04 | 2024 | Metacross Otw, Glidewire |
| Philips North America LLC | $18.30 | 2022 | |
| Novartis Pharmaceuticals Corporation | $14.90 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emmanuel Ekanem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.